Cigarette Smoking Following Lung Transplantation
| Autor: | David R. Nunley, Gerene Bauldoff, Christopher Holloman, Staci Carter, Amy Pope-Harman |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Graft Rejection Male Pulmonary and Respiratory Medicine medicine.medical_specialty medicine.medical_treatment media_common.quotation_subject Bronchiolitis obliterans Pulmonary function testing Cigarette smoking Internal medicine Exercise performance medicine Humans Lung transplantation Lung Retrospective Studies media_common business.industry Smoking Rehabilitation Normal lung function Middle Aged Abstinence Allografts medicine.disease Transplant Recipients humanities Respiratory Function Tests respiratory tract diseases Allograft rejection Female Cardiology and Cardiovascular Medicine business Lung Transplantation |
| Zdroj: | Journal of Cardiopulmonary Rehabilitation and Prevention. 35:147-153 |
| ISSN: | 1932-7501 |
| DOI: | 10.1097/hcr.0000000000000096 |
| Popis: | PURPOSE Despite mandatory tobacco abstinence following lung transplantation (LTX), some recipients resume smoking cigarettes. The effect of smoking on allograft function, exercise performance, and symptomatology is unknown. METHODS A retrospective review was conducted of LTX recipients who received allografts over an 8-year interval and who were subjected to sequential posttransplant pulmonary function testing (PFT), 6-minute walk (6MW) testing, and assessments of exertional dyspnea (Borg score). Using post-LTX PFT results, recipients were determined to have either bronchiolitis obliterans syndrome (BOS), a manifestation of chronic allograft rejection, or normal pulmonary function (non-BOS). With respect to post-LTX pulmonary function, 6MW distances, and Borg scores, comparisons were made between these recipient groups and those who resumed smoking. RESULTS Of 34 LTX recipients identified, 13 maintained normal lung function (non-BOS), while 16 demonstrated a decline in their PFT values consistent with BOS. Five recipients began smoking at median postoperative day 365 and smoked 1 pack per day for a mean of 485.6 days. Smokers developed a deterioration of their PFT values that was similar to those with BOS (P = .47) and tended to be worse than those in the non-BOS group (P = .09). All smokers experienced a decline in 6MW distances similar to those with BOS and non-BOS but reported less exertional dyspnea (lower Borg scores) than those with BOS. CONCLUSION Recipients of LTX who resume cigarette smoking demonstrate a decline in pulmonary function similar to those afflicted with chronic allograft rejection but do not experience a decrement in their functional performance or increased dyspnea. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|